Alcohol Use Disorder Market to Grow Positively at a Paltry CAGR During the Study Period (2020-2034) | Adial Pharmaceuticals, MediciNova, Corcept Therapeutics, expected to boost the market

United States, Nevada, Las Vegas, DelveInsight's "Alcohol Use Disorder - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Alcohol Use Disorder market share of the individual therapies, current and forecasted Alcohol Use Disorder market size from 2020 to 2034 segmented by seven major markets. The report also offers current Alcohol Use Disorder therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Alcohol Use Disorder market.
Request for sample pages @ https://www.delveinsight.com/report-store/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Alcohol Use Disorder Overview
Overview

Alcohol Use Disorder (AUD) is a chronic, relapsing condition characterized by an inability to control alcohol consumption despite adverse consequences. It affects both physical and mental health and can significantly impair an individual's ability to function in daily life. AUD is recognized as a medical condition that requires comprehensive treatment and management.

Causes

The development of AUD is influenced by a combination of genetic, environmental, and psychological factors:

1. Genetic Factors:
- Family History: A genetic predisposition can increase the risk of developing AUD. Research indicates that genetic factors may account for 40-60% of the risk.
- Genetic Variations: Certain genetic variations can affect how alcohol is metabolized and its effects on the brain.

2. Environmental Factors:
- Social and Cultural Influences: Exposure to alcohol use in the family, peer pressure, and cultural attitudes towards drinking can impact the likelihood of developing AUD.
- Trauma and Stress: Experiences of trauma, abuse, or significant stress can contribute to alcohol misuse as a coping mechanism.

3. Psychological Factors:
- Mental Health Disorders: Conditions such as depression, anxiety, or bipolar disorder can co-occur with AUD and complicate treatment.
- Personality Traits: Traits such as impulsivity and risk-taking behavior are associated with a higher risk of developing AUD.

4. Biological Factors:
- Brain Chemistry: Changes in brain chemistry and function due to chronic alcohol use can reinforce addiction and dependence.

Signs and Symptoms

Signs and symptoms of AUD can range from mild to severe and include:

- Increased Tolerance: Need to consume more alcohol to achieve the same effects.
- Withdrawal Symptoms: Physical symptoms such as tremors, sweating, nausea, and anxiety when alcohol use is reduced or stopped.
- Cravings: Strong, persistent desire or urge to drink alcohol.
- Loss of Control: Inability to limit or control alcohol consumption despite attempts to cut down.
- Neglect of Responsibilities: Failure to meet obligations at work, school, or home due to alcohol use.
- Continued Use Despite Harm: Drinking even though it leads to physical, psychological, or social problems.
- Impaired Functioning: Difficulty in performing daily activities, including maintaining relationships and managing finances.
- Spending Excessive Time: Devoting significant time to obtaining, using, or recovering from alcohol.

Diagnosis

The diagnosis of AUD is based on clinical assessment and diagnostic criteria:

1. Clinical Evaluation:
- Medical History: Discussion of drinking patterns, physical and mental health, and any related issues.
- Physical Examination: To assess for signs of alcohol-related health problems such as liver disease or nutritional deficiencies.

2. Diagnostic Criteria:
- DSM-5 Criteria: The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), provides criteria for diagnosing AUD. Diagnosis requires meeting at least two of the following criteria within a 12-month period:
- Drinking more or for longer periods than intended.
- Persistent desire or unsuccessful efforts to cut down or control drinking.
- Spending a lot of time obtaining, using, or recovering from alcohol.
- Craving or a strong desire to drink.
- Recurrent alcohol use resulting in failure to fulfill major obligations.
- Continued use despite social or interpersonal problems.
- Important social, occupational, or recreational activities are given up or reduced.
- Recurrent use in situations where it is physically hazardous.
- Continued use despite physical or psychological problems.
- Tolerance and withdrawal symptoms.

3. Laboratory Tests:
- Blood Tests: To check for liver function abnormalities (e.g., elevated liver enzymes), anemia, or other alcohol-related health issues.
- Screening Tools: Standardized questionnaires and screening tools like the AUDIT (Alcohol Use Disorders Identification Test) or CAGE questionnaire to assess the extent of alcohol use and associated problems.

Treatment Options

Treatment for AUD is typically multifaceted and may include a combination of therapies:

1. Behavioral Therapies:
- Cognitive-Behavioral Therapy (CBT): Helps individuals recognize and change negative thought patterns and behaviors related to alcohol use.
- Motivational Interviewing: Focuses on enhancing the individual's motivation to change their drinking behavior.
- Contingency Management: Provides incentives for maintaining abstinence or achieving treatment goals.

2. Pharmacotherapy:
- Medications: Several medications can support recovery, including:
- Disulfiram (Antabuse): Causes unpleasant reactions when alcohol is consumed, which can deter drinking.
- Naltrexone (ReVia, Vivitrol): Reduces cravings for alcohol and decreases the pleasure associated with drinking.
- Acamprosate (Campral): Helps maintain abstinence by stabilizing brain chemistry.
- Topiramate (Topamax): Sometimes used off-label to reduce drinking and cravings.

3. Supportive Services:
- Alcoholics Anonymous (AA): A support group that follows a 12-step program and provides peer support for maintaining sobriety.
- Group Therapy: Provides support and encouragement from others in similar situations.
- Family Therapy: Addresses family dynamics and supports the individual's recovery.

4. Medical Management:
- Detoxification: Medical supervision to safely manage withdrawal symptoms when stopping alcohol use.
- Treatment of Co-occurring Disorders: Addressing any co-existing mental health conditions or other substance use disorders.

5. Rehabilitation Programs:
- Inpatient Rehab: Residential treatment programs that offer intensive therapy and medical care.
- Outpatient Rehab: Allows individuals to receive treatment while continuing to live at home and maintain their daily responsibilities.

6. Long-term Management:
- Relapse Prevention: Ongoing support and strategies to prevent relapse and maintain sobriety.
- Lifestyle Changes: Encouraging healthy behaviors and coping mechanisms to support long-term recovery.

Prognosis

The prognosis for AUD varies depending on factors such as the severity of the disorder, the presence of co-occurring conditions, and the effectiveness of the treatment. With appropriate intervention and support, many individuals with AUD can achieve and maintain sobriety, improve their overall quality of life, and reduce the risk of alcohol-related complications. Early intervention and a comprehensive treatment approach are key to improving outcomes and supporting long-term recovery.

Alcohol Use Disorder Epidemiological Insights
According to estimates based on DelveInsight's epidemiology model for AUD, the type-specific distribution of the disease suggests that young adults make up the majority of the AUD cases (32%), followed by young antisocial cases (21%). While there were least cases of the chronic severe type.
Download free sample report on alcohol use disorder treatment market @ https://www.delveinsight.com/report-store/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Alcohol Use Disorder Treatment Market
AUD also has economic consequences, costing a substantial amount annually. Current pharmaceutical and behavioral treatments may assist patients in reducing alcohol use or facilitating alcohol abstinence.

At present, there are four approved therapies for the treatment of AUD that includes disulfiram, Naltrexone (oral), acamprosate, and VIVITROL. Most of these therapies were approved decades ago and have their generics in the market. The current AUD market in the US is dominated by these therapies.
Promising Therapies in the Alcohol Use Disorder Pipeline
AD04 (ondansetron)
MN-166 (ibudilast)
CORT118335 (mifepristone)
And others
Discover more about Alcohol Use Disorder therapies in the pipeline @ https://www.delveinsight.com/sample-request/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Leading Companies Working in the Alcohol Use Disorder Market
Adial Pharmaceuticals
MediciNova
Corcept Therapeutics
And others
To understand key companies related to the Alcohol Use Disorder Market, get a snapshot of the Alcohol Use Disorder Regulatory and Patent Analysis @ https://www.delveinsight.com/sample-request/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Alcohol Use Disorder Market Report
Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Alcohol Use Disorder Companies: Adial Pharmaceuticals, MediciNova, Corcept Therapeutics, and others
Key Alcohol Use Disorder Pipeline Therapies: AD04 (ondansetron), MN-166 (ibudilast), CORT118335 (mifepristone), and others
Therapeutic Assessment: Alcohol Use Disorder current marketed and emerging therapies
Alcohol Use Disorder Market Dynamics: Alcohol Use Disorder market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Alcohol Use Disorder Market Access and Reimbursement
Table of Contents
1. Alcohol Use Disorder Market Key Insights
2. Alcohol Use Disorder Market Report Introduction
3. Alcohol Use Disorder Market Overview at a Glance
4. Alcohol Use Disorder Market Executive Summary
5. Disease Background and Overview
6. Alcohol Use Disorder Treatment and Management
7. Alcohol Use Disorder Epidemiology and Patient Population
8. Patient Journey
9. Alcohol Use Disorder Emerging Drugs
10. 7MM Alcohol Use Disorder Market Analysis
11. Alcohol Use Disorder Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Alcohol Use Disorder Market Drivers
15. Alcohol Use Disorder Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Request for a sample report @ https://www.delveinsight.com/sample-request/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Trending Reports by DelveInsight:

Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market

Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679

About DelveInsight:

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.